Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium periodate | HCID 23667635 | — |
| Reactant | HCID 54432397 | HCID 54432397 | — |
| Catalyst | Ruthenium dioxide hydrate | HCID 16211523 | — |
| Solvent | Acetone | HCID 180 | — |
| Solvent | Water | HCID 962 | — |
| Product | HCID 69972743 | HCID 69972743 | 102.4% |
Reaction Steps
Ruthenium (IV) oxide hydrate (238 mg) was added to a solution of (2R,5R)-4-(tert-butoxycarbonyl)-2-hydroxymethyl-1-(4-methoxybenzenesulfonyl)-5-(2-methylpropyl)piperazine (5.3 g) in acetone (50 ml) and H2O (20 ml), followed by addition of sodium periodate (5.1 g) with cooling on an ice bath. After stirring at the same temperature for 40 minutes, the reaction was quenched with 2-propanol (50 ml). Insoluble matter was removed by filtration through a celite pad, and the filtrate was washed with acetone and AcOEt. The filtrate and combined washings were concentrated in vacuo, and the residue was partitioned by dissolving same in 5% aqueous sodium bisulfite and AcOEt. The organic layer was washed with saturated NaCl solution, dried over MgS04, and concentrated in vacuo to give 5.6 g of (2R,5R)-4-(tert-butoxycarbonyl)-1-(4-methoxybenzenesulfonyl)-5-(2-methylpropyl)piperazine-2-carboxylic acid as an amorphous powder.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06333324B1 |
|---|
| Source dataset | uspto-grants-2001_12 |
|---|
| ORD ID | ord-8e7a73dc37634cedb71a6c672b18acb3 |
|---|
| Source note | uspto-grants-2001_12 |
|---|